glp-1 agonist drugs oral Drugs: How the New Weight Loss Pills Work FDA approves first oral GLP-1

self-monitoring of body weight, food intake, and activity

However, the 2019 ESC guidelines recommended SGLT-2s and GLP-1s as first-line drugs over metformin in people with diabetes who have heart disease or a high risk for heart disease

Similar content being viewed by others Log in or create a free account to read this content Gain free access to this article, as well as selected content from this journal and more on nature.com or Accession codes Accessions GenBank/EMBL/DDBJ References Acuna-Goycolea C, van den Pol A (2004)

While they also help with meal replacement, don't overdo them

The absolute risk increase for diabetic retinopathy complications was larger among patients with a history of diabetic retinopathy at baseline than among patients without a known history of diabetic retinopathy